Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vincerx Pharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vincerx Pharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Thomas Tom C | See Remarks | 219,935 | Aug 14, 2024 | 0 |
| Hamdy Ahmed MD | Chief Executive Officer | 96,060Indirect | Aug 14, 2024 | 0 |
| Izumi Raquel E. | See Remarks | 85,214Indirect | Aug 14, 2024 | 0 |
| Seelenberger Alexander A. | Chief Financial Officer | 30,280 | Aug 14, 2024 | 0 |
| Druker Brian | Director | – | May 28, 2024 | 0 |
| Bushnell Laura I. | Director | 19,202 | May 28, 2024 | 0 |
| Salva Francisco D. | Director | – | May 28, 2024 | 0 |
| Lee John H. | Director | 799 | May 28, 2024 | 0 |
| Stevens Ruth E. | Director | – | May 28, 2024 | 0 |
| Lowe Christopher P. | Director | 40,000 | Aug 26, 2022 | 0 |
| McDonald Andrew I | Director, 10% Owner | 20,000 | May 31, 2022 | 0 |
| Garban Hermes de Jesus | Chief Medical Officer | – | Feb 16, 2022 | 0 |
| Hwang Sooin | Chief Business Officer | 390,491 | Feb 16, 2022 | 0 |
| Zhang Xiaoming | Chief Technology Officer | – | Feb 16, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | McDonald Andrew IDirector | PPurchase | +20.0K | $12.38 | +$247.6K | New position20.0K after | |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Lee John H.Director | PPurchase | +799 | $12.72 | +$10.2K | New position799 after | |
| Aug 6, 2021 (view filing) | Aug 4 | 2 days | Izumi Raquel E.See Remarks | PPurchase | +1.00K | $11.96 | +$12.0K | New position1.00K after | |
| Dec 27, 2021 (view filing) | Dec 22 | 5 days | Hamdy Ahmed MDChief Executive Officer | PPurchase | +6.45K | $10.02 | +$64.6K | +82.4%14.3K after | |
| Dec 27, 2021 (view filing) | Dec 22 | 5 days | Seelenberger Alexander A.Chief Financial Officer | PPurchase | +2.42K | $10.34 | +$25.0K | +24.0%12.5K after | |
| Dec 27, 2021 (view filing) | Dec 22 | 5 days | Bushnell Laura I.Director | PPurchase | +2.40K | $10.48 | +$25.2K | +133.4%4.20K after | |
| Dec 27, 2021 (view filing) | Dec 23 | 4 days | Hwang SooinChief Business Officer | PPurchase | +3.00K | $10.00 | +$30.0K | +0.8%390.5K after | |
| Dec 27, 2021 (view filing) | Dec 22 | 5 days | Thomas Tom CSee Remarks | PPurchase | +1.00K | $10.23 | +$10.2K | +50.0%3.00K after | |
| Jun 13, 2022 (view filing) | Jun 9 | 4 days | Bushnell Laura I.Director | PPurchase | +15.0K | $1.91 | +$28.6K | +357.0%19.2K after | |
| Jun 27, 2022 (view filing) | Jun 23 | 4 days | Hamdy Ahmed MDChief Executive Officer | PPurchase | +24.2K | $1.41 | +$34.1K | +169.5%38.5K after | |
| Jun 29, 2022 (view filing) | Jun 27 | 2 days | Izumi Raquel E.See Remarks | PPurchase | +40.0K | $1.41 | +$56.4K | New position40.0K after | |
| Aug 26, 2022 (view filing) | Aug 24-25 | 2 days | Lowe Christopher P.Director | PPurchase | +30.0K | $1.65 | +$49.5K | +300.0%40.0K after | 2 lots |
| Dec 14, 2022 (view filing) | Dec 14 | Same day | Thomas Tom CSee Remarks | PPurchase | +7.00K | $0.83 | +$5.81K | +233.3%10.0K after | |
| Dec 14, 2022 (view filing) | Dec 14 | Same day | Hamdy Ahmed MDChief Executive Officer | PPurchase | +35.3K | $0.87 | +$30.7K | +91.7%73.8K after | |
| Dec 14, 2022 (view filing) | Dec 14 | Same day | Izumi Raquel E.See Remarks | PPurchase | +28.7K | $0.88 | +$25.3K | +71.8%68.7K after | |
| Aug 10, 2023 (view filing) | Aug 9-10 | 1 day | Izumi Raquel E.See Remarks | PPurchase | +16.5K | $0.9063 | +$14.9K | +24.0%85.2K after | 2 lots |
| Aug 10, 2023 (view filing) | Aug 10 | Same day | Thomas Tom CSee Remarks | PPurchase | +5.00K | $0.95 | +$4.75K | +2.3%219.9K after | |
| Aug 10, 2023 (view filing) | Aug 9-10 | 1 day | Hamdy Ahmed MDSee Remarks | PPurchase | +22.3K | $0.9524 | +$21.2K | +30.2%96.1K after | 2 lots |
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Seelenberger Alexander A.See Remarks | PPurchase | +10.5K | $0.95 | +$9.97K | +53.1%30.3K after |